Roche said the late-stage trial did not provide reliable evidence that ​the drug's use in combination with Pfizer's Ibrance ...

FRANKFURT, March 9 (Reuters) - Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

Surgeon Gareth Honeybone wants wider access to zanidatamab to treat one of the deadliest cancers.

Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...

Indian national Sanjay Kumar has been sentenced to nearly four years in prison for carrying out a conspiracy to sell fake ...

The drug is sometimes prescribed to certain at-risk people—but what does the science say?

But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

As a full-time practicing medical oncologist in Winchester, I spend my days with Virginians who bravely fight cancer. Sadly, ...

Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so people who are on it need to ...